Loading
PB
PDL Biopharma, Inc. Stock: price and insider trades · United States
PDL Biopharma, Inc.: what insiders have been doing
Only a handful of insider records exist for PDL Biopharma, Inc., the last one from 28 January 2016, too few to describe a trend. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 28 January 2016
Declarations6 total
30,693 sharesCommon stockSEC:0000882104-16-000090:0
101,051 sharesCommon stockSEC:0000882104-16-000098:0
94,565 sharesCommon stockSEC:0000882104-16-000097:0
403,727 sharesCommon stockSEC:0000882104-16-000096:0
101,860 sharesCommon stockSEC:0000882104-16-000099:0
31,135 sharesCommon stockSEC:0000882104-16-000100:0
6 of 6 declarations
About PDL Biopharma, Inc.
PDL Biopharma, Inc. is a company focused on the development and commercialization of biopharmaceutical products. It aims to provide innovative solutions for the treatment of serious diseases.
